tradingkey.logo

tradingkey.logo
怜玢


Twist Bioscience Corp

TWST
りォッチリストに远加
91.550USD
+0.220+0.24%
終倀 07-31 16:00ET15分遅れの株䟡
5.69B時䟡総額
損倱額盎近12ヶ月PER

詳现情報 Twist Bioscience Corp 䌁業名

Twist Bioscience Corporation is a synthetic biology and genomics company that has developed a deoxyribonucleic acid (DNA) synthesis platform to industrialize the engineering of biology. The Company's platform's core is a proprietary technology that specializes in manufacturing synthetic DNA by writing DNA on a silicon chip. It has applied its technology to manufacture a range of synthetic DNA-based products, including synthetic genes, tools for next generation sequencing (NGS) sample preparation, and antibody libraries for drug discovery and development, all designed to enable its customers to conduct research. Its gene products include multiplexed gene fragments, express genes, clonal genes and gene fragments. The Company also manufactures synthetic ribonucleic acid (RNA) as well as antibody proteins. The Company's synthetic DNA tools are used in fields, such as medicine, agriculture, industrial chemicals and defense. It has minority ownership in Atlas Data Storage, Inc.

Twist Bioscience Corpの䌁業情報


䌁業コヌドTWST
䌚瀟名Twist Bioscience Corp
䞊堎日Oct 31, 2018
最高経営責任者「CEO」Leproust (Emily M)
埓業員数979
蚌刞皮類Ordinary Share
決算期末Oct 31
本瀟所圚地681 Gateway Blvd.
郜垂SOUTH SAN FRANCISCO
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜United States of America
郵䟿番号94080
電話番号18007190671
りェブサむトhttps://www.twistbioscience.com/
䌁業コヌドTWST
䞊堎日Oct 31, 2018
最高経営責任者「CEO」Leproust (Emily M)

Twist Bioscience Corpの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
368.47K
-6.20%
Mr. Keith L. Crandell
Mr. Keith L. Crandell
Independent Director
Independent Director
99.15K
+5.14%
Mr. Patrick John Finn, Ph.D.
Mr. Patrick John Finn, Ph.D.
President, Chief Operating Officer
President, Chief Operating Officer
65.04K
-10.77%
Mr. Nelson C. Chan
Mr. Nelson C. Chan
Independent Director
Independent Director
28.78K
+17.70%
Ms. Paula Green
Ms. Paula Green
Senior Vice President - Human Resources
Senior Vice President - Human Resources
23.50K
-5.00%
Mr. Dennis Cho
Mr. Dennis Cho
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
21.34K
-70.08%
Dr. Melissa A. Starovasnik, Ph.D.
Dr. Melissa A. Starovasnik, Ph.D.
Independent Director
Independent Director
17.75K
-16.90%
Mr. Jan Johannessen
Mr. Jan Johannessen
Independent Director
Independent Director
13.28K
--
Mr. Adam Laponis
Mr. Adam Laponis
Chief Financial Officer
Chief Financial Officer
4.72K
-50.85%
Mr. Robert B. (Rob) Chess
Mr. Robert B. (Rob) Chess
Lead Independent Director
Lead Independent Director
--
--
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
368.47K
-6.20%
Mr. Keith L. Crandell
Mr. Keith L. Crandell
Independent Director
Independent Director
99.15K
+5.14%
Mr. Patrick John Finn, Ph.D.
Mr. Patrick John Finn, Ph.D.
President, Chief Operating Officer
President, Chief Operating Officer
65.04K
-10.77%
Mr. Nelson C. Chan
Mr. Nelson C. Chan
Independent Director
Independent Director
28.78K
+17.70%
Ms. Paula Green
Ms. Paula Green
Senior Vice President - Human Resources
Senior Vice President - Human Resources
23.50K
-5.00%
Mr. Dennis Cho
Mr. Dennis Cho
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
21.34K
-70.08%

よくある質問

Twist Bioscience Corpの䞊䜍5名の株䞻は誰ですか


Twist Bioscience Corpの䞊䜍5名の株䞻は以䞋のずおりです。Dr. Emily M. Leproust, Ph.D.

Twist Bioscience CorpTWSTの株匏を保有しおいる機関の数はいく぀ですか


2026Q1時点で、Twist Bioscience Corpの株匏を保有しおいる機関は592瀟あり、保有株匏の総垂堎䟡倀は玄78.48Mで、党䜓の126.03%を占めおいたす。2025Q4ず比范しお、機関の持ち株は-339291.00増加しおいたす。

Twist Bioscience Corpの最倧の収益源は䜕ですか


2026Q1においお、NGS applications郚門がTwist Bioscience Corpにずっお最倧の収益を生み出しおおり、その金額は52.64Mで、党収益の50.76%を占めおいたす。
tradingkey.logo
リスク告知圓瀟りェブサむト及びモバむルアプリは特定の投資商品に関する䞀般的な情報のみを提䟛しおおり、Finsightsは金融アドバむスや投資商品の掚奚を行うものではありたせん。本情報の提䟛をもっおFinsightsが投資助蚀を行っおいるず解釈されるこずはありたせん。
投資商品には元本割れを含む重倧なリスクが䌎い、党おの投資家に適するものではありたせん。なお、過去の運甚実瞟は将来の成果を保蚌するものではありたせん。
Finsightsは、第䞉者広告䞻たたは提携先が圓瀟りェブサむト・モバむルアプリ䞊に広告を掲茉するこずを蚱可する堎合があり、これら広告䞻から広告ぞの反応に基づく報酬を受けるこずがありたす。
© 著䜜暩: FINSIGHTS MEDIA PTE. LTD. 無断耇写・転茉を犁じたす。